| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |